1. Home
  2. CHMI vs ASMB Comparison

CHMI vs ASMB Comparison

Compare CHMI & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • ASMB
  • Stock Information
  • Founded
  • CHMI 2012
  • ASMB 2005
  • Country
  • CHMI United States
  • ASMB United States
  • Employees
  • CHMI N/A
  • ASMB N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • ASMB Health Care
  • Exchange
  • CHMI Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • CHMI 96.0M
  • ASMB 130.2M
  • IPO Year
  • CHMI 2013
  • ASMB 2010
  • Fundamental
  • Price
  • CHMI $2.75
  • ASMB $18.25
  • Analyst Decision
  • CHMI Hold
  • ASMB Strong Buy
  • Analyst Count
  • CHMI 2
  • ASMB 3
  • Target Price
  • CHMI N/A
  • ASMB $33.00
  • AVG Volume (30 Days)
  • CHMI 285.7K
  • ASMB 34.2K
  • Earning Date
  • CHMI 08-07-2025
  • ASMB 08-07-2025
  • Dividend Yield
  • CHMI 21.90%
  • ASMB N/A
  • EPS Growth
  • CHMI N/A
  • ASMB N/A
  • EPS
  • CHMI N/A
  • ASMB N/A
  • Revenue
  • CHMI $27,506,000.00
  • ASMB $32,154,000.00
  • Revenue This Year
  • CHMI N/A
  • ASMB $0.04
  • Revenue Next Year
  • CHMI $54.92
  • ASMB N/A
  • P/E Ratio
  • CHMI N/A
  • ASMB N/A
  • Revenue Growth
  • CHMI 19.59
  • ASMB 148.33
  • 52 Week Low
  • CHMI $2.34
  • ASMB $7.75
  • 52 Week High
  • CHMI $3.95
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 47.62
  • ASMB 68.97
  • Support Level
  • CHMI $2.93
  • ASMB $16.50
  • Resistance Level
  • CHMI $3.04
  • ASMB $17.86
  • Average True Range (ATR)
  • CHMI 0.06
  • ASMB 0.76
  • MACD
  • CHMI 0.00
  • ASMB -0.11
  • Stochastic Oscillator
  • CHMI 47.06
  • ASMB 82.96

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: